Attached files
| file | filename |
|---|---|
| EX-31.1 - 090331_ASB_FORM 10K-A_AMENDMENT NO 1_EX 31.1 - EKIMAS Corp | asbform10ka1_ex31-1.htm |
| EX-10.8 - 090331_ASB_FORM 10K-A_AMENDMENT NO 1_EX 10.8 - EKIMAS Corp | asbform10ka1_ex10-8.htm |
| EX-31.2 - 090331_ASB_FORM 10K-A_AMENDMENT NO 1_EX 31.2 - EKIMAS Corp | asbform10ka1_ex31-2.htm |
| EX-32.2 - 090331_ASB_FORM 10K-A_AMENDMENT NO 1_EX 32.2 - EKIMAS Corp | asbform10ka1_ex32-2.htm |
| 10-K/A - 090331_ASB_FORM 10K-A_AMENDMENT NO 1_FILED 091211 - EKIMAS Corp | asbform10ka1_090331.htm |
Exhibit
32.1
In
connection with the Annual Report of AdvanSource Biomaterials Corporation, a
Delaware corporation (the “Company”), on Form 10-K/A for the fiscal year ended
March 31, 2009, as filed with the Securities and Exchange Commission on the date
hereof (the “Report”), I, Michael F. Adams, Chief Executive Officer and
President of the Company, hereby certify, pursuant to 18 U.S.C. Section 1350, as
adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the
best of my knowledge:
(1) The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operations of the Company.
|
/s/
Michael F. Adams
|
|
|
Michael
F. Adams
|
|
|
Chief
Executive Officer and President
|
|
|
Date:
December 11, 2009
|
|
This
certification accompanies each report of the Company on Form 10-Q, Form 10-K and
Form 10-K/A pursuant to §906 of the Sarbanes-Oxley Act of 2002 and shall not,
except to the extent required by the Sarbanes-Oxley Act of 2002, be deemed filed
by the Company for purposes of §18 of the Securities Exchange Act of 1934, as
amended.
A signed
original of this written statement required by §906 has been provided to the
Company and will be retained by the Company and furnished to the Securities and
Exchange Commission or its staff upon request.